CHEK1 and neoplasm: By contrast, tumor cells with moderate replication stress that feature reserve RPA and delayed S-phase progression, can nonetheless be pushed to RPA exhaustion, S-phase arrest, and DNA damage-induced cell death by CHK1 inhibitors that activate late origin firing44.